These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32567984)

  • 41. Tranexamic acid in melasma: A focused review on drug administration routes.
    Konisky H; Balazic E; Jaller JA; Khanna U; Kobets K
    J Cosmet Dermatol; 2023 Apr; 22(4):1197-1206. PubMed ID: 36606378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet-rich plasma treatment for melasma: A pilot study.
    Sirithanabadeekul P; Dannarongchai A; Suwanchinda A
    J Cosmet Dermatol; 2020 Jun; 19(6):1321-1327. PubMed ID: 31568636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Laser-assisted delivery of tranexamic acid for melasma: Pilot study using a novel 1927 nm fractional thulium fiber laser.
    Wang JV; Christman MP; Feng H; Ferzli G; Jeon H; Geronemus RG
    J Cosmet Dermatol; 2021 Jan; 20(1):105-109. PubMed ID: 33174686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platelet-rich plasma is a useful therapeutic option in melasma.
    Hofny ERM; Abdel-Motaleb AA; Ghazally A; Ahmed AM; Hussein MRA
    J Dermatolog Treat; 2019 Jun; 30(4):396-401. PubMed ID: 30220226
    [No Abstract]   [Full Text] [Related]  

  • 45. Randomized, double-blind, placebo-controlled split-face trial of the efficacy of tranexamic acid by drug delivery through microneedling in the treatment of melasma.
    Kuster Kaminski Arida D; Orso Rebellato PR; Marioto de Campos GL; Costa A; Vilaverde Schmitt J; Larocca Skare T; Rodrigues Lisboa Faucz L
    J Cosmet Dermatol; 2021 Dec; 20(12):4005-4010. PubMed ID: 34077619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical observation and dermoscopy evaluation of fractional CO
    Qu Y; Wang F; Liu J; Xia X
    J Cosmet Dermatol; 2021 Apr; 20(4):1110-1116. PubMed ID: 33565243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of Trichloro-Acetic Acid Peel Alone Versus Combined Topical Magnesium Ascorbyl Phosphate for Epidermal Melasma.
    Murtaza F; Bangash AR; Khushdil A; Noor SM
    J Coll Physicians Surg Pak; 2016 Jul; 26(7):557-61. PubMed ID: 27504543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The efficacy and safety of topical tranexamic acid (liposomal or lotion with microneedling) versus conventional hydroquinone in the treatment of melasma.
    Xing X; Chen L; Xu Z; Jin S; Zhang C; Xiang L
    J Cosmet Dermatol; 2020 Dec; 19(12):3238-3244. PubMed ID: 33091202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The efficacy and safety of microneedling with topical tranexamic acid for melasma treatment: A systematic review and meta-analysis.
    Feng X; Su H; Xie J
    J Cosmet Dermatol; 2024 Jan; 23(1):33-43. PubMed ID: 37584240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histological changes in facial melasma after treatment with triple combination cream with or without oral tranexamic acid and/or microneedling: A randomised clinical trial.
    Cassiano DP; Espósito ACC; Hassun KM; Lima MMDA; Lima EVA; Miot LDB; Miot HA; Bagatin E
    Indian J Dermatol Venereol Leprol; 2022; 88(6):761-770. PubMed ID: 35389028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative efficacy and safety of tranexamic acid for melasma by different administration methods: A systematic review and network meta-analysis.
    Liang R; Luo H; Pan W; Yang S; Peng X; Kuang B; Huang H; Liu C
    J Cosmet Dermatol; 2024 Apr; 23(4):1150-1164. PubMed ID: 38059683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study.
    Zhu CY; Li Y; Sun QN; Takada A; Kawada A
    Eur J Dermatol; 2019 Feb; 29(1):55-58. PubMed ID: 30734717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma.
    Laothaworn V; Juntongjin P
    J Cosmet Laser Ther; 2018 Oct; 20(6):320-325. PubMed ID: 29461121
    [No Abstract]   [Full Text] [Related]  

  • 54. Therapeutic efficiency and safety assessment of intradermal platelet-rich plasma combined with oral tranexamic acid in patients with facial melasma.
    Tawanwongsri W; Siri-Archawawat D; Sindhusen S; Eden C
    Adv Clin Exp Med; 2024 Jun; ():. PubMed ID: 38934336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liposomal azelaic acid 20% cream vs hydroquinone 4% cream as adjuvant to oral tranexamic acid in melasma: a comparative study.
    Akl EM
    J Dermatolog Treat; 2022 Jun; 33(4):2008-2013. PubMed ID: 33823725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma.
    Khurana VK; Misri RR; Agarwal S; Thole AV; Kumar S; Anand T
    Indian J Dermatol Venereol Leprol; 2019; 85(1):39-43. PubMed ID: 30333359
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic efficacy and safety of oral tranexamic acid 250 mg once a day versus 500 mg twice a day: a comparative study.
    Chowdhary B; Mahajan VK; Mehta KS; Chauhan PS; Sharma V; Sharma A; Vashist S; Kumar P
    Arch Dermatol Res; 2021 Mar; 313(2):109-117. PubMed ID: 32356007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Intense Pulsed Light versus Intradermal Tranexamic Acid for the Management of Melasma.
    Asim SA; Iqbal T; Sajid M; Bhatti S
    J Coll Physicians Surg Pak; 2024 May; 34(5):522-526. PubMed ID: 38720210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of oral tranexamic acid as an adjuvant in Indian patients with melasma: a prospective, interventional, single-centre, triple-blind, randomized, placebo-control, parallel group study.
    Minni K; Poojary S
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2636-2644. PubMed ID: 32567734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life.
    Dayal S; Sahu P; Dua R
    J Cosmet Dermatol; 2017 Mar; 16(1):35-42. PubMed ID: 27500896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.